| Japanese |
|---|
| Title | 甲状腺機能亢進症に合併した鉄欠乏性貧血による甲状腺機能の抑制について |
|---|
| Subtitle | 臨床報告 |
|---|
| Authors | 斎藤宏* |
|---|
| Authors(kana) | |
|---|
| Organization | *名古屋大学医学部放射線科 |
|---|
| Journal | 核医学 |
|---|
| Volume | 14 |
|---|
| Number | 2 |
|---|
| Page | 291-295 |
|---|
| Year/Month | 1977/4 |
|---|
| Article | 報告 |
|---|
| Publisher | 日本核医学会 |
|---|
| Abstract | 131Iによる甲状腺機能亢進症の治療経過中に鉄欠乏性貧血を合併し, 鉄欠乏性貧血の治癒と再発にともなって甲状腺機能が昇降した症例 (1) と鉄欠乏性貧血の治癒にともなって甲状腺機能亢進症状が顕在化した症例 (2) とを経験したので甲状腺機能と鉄欠乏性貧血との関係について考察を加えた. 「症例1」氏名CH 年齢32歳, 女性, 既婚, 子供はない 家族歴 母 : 糖尿病, 兄 : 肥満, 高血圧 既往 5歳のとき前額部外傷, 昭和45年流産 現症 昭和47年2月15日頃より背部痛あり 守山市民病院を受診し, 甲状腺機能亢進症と診断された. 来院時所見ならびに経過 不安, 興奮状態で医療に不信感を表明し, 診察に応じようとしなかったが, 家人と筆者の強い説得によりアイソトープ検査を行うことができた. 当日のRT3U 53%, T4 33μg/100ml, 131I 摂取率 74%, 甲状腺シンチグラム右6.0cm×3.0cm, 左6.0cm×3.0cm. 昭和47年 (1972年) 3月17日, 第1回治療量として131I 5mCi投与. 5月16日来診時, 体重 49Kg, 頭重感, 胸部圧迫感を訴えたが口渇は軽減した. |
|---|
| Practice | 臨床医学：一般 |
|---|
| Keywords | |
|---|
| English |
|---|
| Title | Suppression of Thyroid Function by Iron Deficiency Anemia |
|---|
| Subtitle | |
|---|
| Authors | Hiroshi SAITO |
|---|
| Authors(kana) | |
|---|
| Organization | 名古屋大学医学部放射線科 |
|---|
| Journal | The Japanese Journal of nuclear medicine |
|---|
| Volume | 14 |
|---|
| Number | 2 |
|---|
| Page | 291-295 |
|---|
| Year/Month | 1977/4 |
|---|
| Article | Report |
|---|
| Publisher | THE JAPANESE SOCIETY OF NUCLEAR MEDICINE |
|---|
| Abstract | [Summary] The increase of thyroid function was observed in the course of treatment of iron deficiency anemia in patient with hyperthyroidism and iron deficiency anemia. In the first case, the patient had myoma uteri, ovarial cyst and showed hypermenorrhea. She was never be hypothyroid throughout 3 year course of following up. The thyroid function was elevated when iron deficiency anemia was cured, and it was lowered when iron deficiency anemia was marked. The anemia was found after the treatment with 131I, and the change of iron deficiency anemia and thyroid function was synchronized. In the second case, iron deficiency anemia, vas found and treated before the 131I-treatment to hyperthyroidism. In the course of recovery of iron deficiency anemia, thyroid function was increased gradually, and the symptom of hyperthyroidism was unveiled. It seems that the thyroid function was suppressed by the presence of iron deficiency anemia, since no explainable evidence was found for the synchronized change of thyroid function and iron deficiency anemia, except the effect of iron deficiency anemia to thyroid function. |
|---|
| Practice | Clinical medicine |
|---|
| Keywords | |
|---|